Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Study Protocol

Accepted on 04 Dec 2025

Rifapentine-and moxifloxacin-containing short-course regimens for mild spinal tuberculosis: study protocol for a multicenter, randomized, non-inferiority phase II clinical trial

in Pharmacology of Infectious Diseases

Yue-E Wu
Jing Cao
Li Wang
Ying-Ji Wei
Hui-Xin Liu
Lei Qi
Wen Zhang
Feng Liu
Zhong-Jiao Zhu
Xu-Tao Fan

Frontiers in Pharmacology

Original Research

Accepted on 02 Dec 2025

Activity-Based Chemoproteomic Profiling Reveals the Active Kinome of Leishmania

in Pharmacology of Infectious Diseases

Exequiel O. J. Porta
Karunakaran Kalesh
Patrick G. Steel

Frontiers in Pharmacology

Original Research

Published on 02 Dec 2025

Branched tetrameric lactoferricin peptides modified with diaminopropionic acid exhibit potent antimicrobial and wound-healing activities

in Pharmacology of Infectious Diseases

Nikitha Vavilthota
Gizem Babuççu
Robert A. Cordfunke
Leonie de Boer
Payal Balraadjsing
Bouke K. H. L. Boekema
Jan W. Drijfhout
Martijn Riool
Sebastian A. J. Zaat

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1719557

456 views

Original Research

Accepted on 30 Nov 2025

Bromhexine hydrochloride enhances the therapeutic efficacy of tiamulin against experimental Staphylococcus aureus infection in dogs: Targeting bacterial virulence, boosting antioxidant defense, and improving histopathology

in Pharmacology of Infectious Diseases

Hanem Elgendy
Shimaa R Masoud
Nagwa Sheraiba
Shimaa S Elnahriry
Doaa A Madkour
Reda M S Korany
Hazim Khalifa
Hanaa Y Elnagar

Frontiers in Pharmacology

132 views

Policy and Practice Reviews

Accepted on 30 Nov 2025

Regulatory Considerations for Developing Phage Therapy Medicinal Products for the Treatment of Antimicrobial Resistant Bacterial Infections

in Pharmacology of Infectious Diseases

Ai Fukaya-Shiba
Akiko Ogata
Ryosuke Kuribayashi
Akira Sakurai
Kanako Suzuki
Shunsuke Takadama
Jihei Nishimura
Jumpei Uchiyama
Hiroki Ohge
Takamasa Takeuchi

Frontiers in Pharmacology

310 views

Review

Published on 21 Nov 2025

Antiretroviral therapy and associated drug interactions with cardiovascular drugs: a critical review

in Pharmacology of Infectious Diseases

Marios Spanakis
Konstantinos Alexakis
Petros Ioannou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1685710

734 views

Review

Published on 20 Nov 2025

Design and synthesis of natural antibacterial derivatives for ocular tuberculosis: a comprehensive review

in Pharmacology of Infectious Diseases

Isaiah Osei Duah
Gabriel Amankwah
Josephine Ampong
Sherlene Brown
Bernice Lebene Tettey
Hubert Osei Acheampong
Ruth Boahemaa Awuku
Cynthia Amaning Danquah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1697986

608 views

Original Research

Published on 18 Nov 2025

Efficacy and safety of omadacycline for the treatment of infectious diseases: a real-world, retrospective study of 2587 patients

in Pharmacology of Infectious Diseases

Jian Liu
Jiayi Liu
Huangyi Li
Jiali Pang
Siyun Chen
Jianming Liu
Aijun Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1706601

790 views

Review

Published on 13 Nov 2025

Myasthenia gravis and community-acquired pneumonia: therapeutic challenges

in Pharmacology of Infectious Diseases

Xueying Chen
Jianbo Ding
Jiali Zhang
Haibin Dai
Lingyan Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1695526

915 views

Review

Published on 12 Nov 2025

Polyphenolic compounds in combating MDR periodontal pathogens: current research and future directions

in Pharmacology of Infectious Diseases

Nada Tawfig Hashim
Rasha Babiker
Vivek Padmanabhan
Md Sofiqul Islam
Riham Mohammed
Sivan Padma Priya
Nallan C. S. K. Chaitanya
Shahistha Parveen Dasnadi
Ayman Ahmed
Bakri Gobara Gismalla

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678979

928 views

Original Research

Published on 12 Nov 2025

Tigecycline pharmacodynamics in the hollow fiber system of Mycobacterium avium-complex lung disease and the utility of MICs and time-kill studies in drug development

in Pharmacology of Infectious Diseases

Devyani Deshpande
Shashikant Srivastava
Tawanda Gumbo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1682477

539 views

Original Research

Published on 10 Nov 2025

A novel drug that reduces pneumococcal toxicity by targeting pneumolysin (PLY): efficacy of the traditional Chinese medicine Radix Paeoniae Alba

in Pharmacology of Infectious Diseases

Yan Xu
Jing Han
Yonglin Zhou
Liping Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1609457

753 views

Systematic Review

Published on 06 Nov 2025

Association between point mutations of macrolide-resistant Mycoplasma pneumoniae and clinical antibiotic treatment efficacy: a meta-analysis

in Pharmacology of Infectious Diseases

Rutong Wang
Junfeng He
Yingqi Feng
Mengyao Wang
Chi Zhong
Siqin He
Siqi Tu
Na Wen
Chuan Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1682167

925 views

Original Research

Published on 29 Oct 2025

Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study

in Pharmacology of Infectious Diseases

Weijie Wang
Shiow-Ing Wang
Yang Cheng
Xinchang Wang
Yongsheng Fan
James Cheng-Chung Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1654173

1,474 views

Systematic Review

Published on 29 Oct 2025

Factors affecting the effectiveness and safety of colistin in treating drug-resistant gram-negative bacterial infections: a meta-analysis

in Pharmacology of Infectious Diseases

Pengfei Li
Shiran Li
Jiao Zhang
Siyu Zeng
Zhimin Li
Jinxian Xie
Yong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1625595

1,022 views

Original Research

Published on 27 Oct 2025

Comparative in vitro susceptibility of clinical Leishmania isolates to miltefosine and oleylphosphocholine

in Pharmacology of Infectious Diseases

Ali Khamesipour
Minoo Tasbihi
Akram Mir Amin Mohammadi
Jodie Dixon
David J. Clark
Henry M. Staines
Sanjeev Krishna
Vanessa Yardley
Simon L. Croft
Neal Alexander

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1688856

1,213 views